| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |